The Scientific Imaging Shared Resource (SISR) is a centralized, highly specialized Shared Resource available to all Cancer Center members. The SISR (formerly the Electron Microscope Shared Resource or Central Imaging facility) has been upgraded in 1999 with the addition of instruments, space, and personnel. The SISR now offers expertise in Transmission and Scanning Electron Microscopy, Confocal Laser Scanning Microscopy (CLSM), Fluorescence Microscopy and Image Analysis (IA). Because these methods are technically demanding , requiring expensive and sophisticated instruments, and because the individual Cancer Center members do not use these methods in high frequency to maintain expertise in their execution, these research methods are ideally suited to be offered by a Shared Resource. The SISR is directed by Dr. K.G. Murti who has over 34 years expertise in all of the above areas of microscopy and has published over 100 research papers. He has directed this Shared Resource since 1985 with the help of an electron microscope technician, Mrs. Donna Davis, who has about 40 years experience in histologic and electron microscopy techniques. Another technician, Mr. Ken Barnes was hired in 1999 to help operate the CLSM and IA systems. Mr. Barnes has a Master's degree in Microbiology and considerable computer and graphics experience. The SISR currently occupies about 1,250 sq. ft. of contiguous space in the plaza level of Danny Thomas Tower. The space contains two rooms for two electron microscopes (JEOL1200 EXII TEMSCAN and Phillips 301), a room for Leica TCS NT SP CLSM and IA system, a dark room for EM negative processing, a dark room for print processing, a room for confocal and cryo-EM preparation, an area for sectioning with two Sorvall ultra microtomes and an area for general EM specimen preparation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-25S1
Application #
6602681
Study Section
Project Start
2002-06-24
Project End
2007-02-28
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Sadighi, Zsila S; Curtis, Elizabeth; Zabrowksi, Jennifer et al. (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65:e27063
Wierdl, Monika; Tsurkan, Lyudmila; Chi, Liying et al. (2018) Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol 82:251-263
Penkert, Rhiannon R; Hurwitz, Julia L; Thomas, Paul et al. (2018) Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia. Haematologica 103:e50-e54
Turner, Benjamin L; Brenes-Arguedas, Tania; Condit, Richard (2018) Pervasive phosphorus limitation of tree species but not communities in tropical forests. Nature 555:367-370
Buchman, Cameron D; Chai, Sergio C; Chen, Taosheng (2018) A current structural perspective on PXR and CAR in drug metabolism. Expert Opin Drug Metab Toxicol 14:635-647
Gibbs, E B; Kriwacki, R W (2018) Direct detection of carbon and nitrogen nuclei for high-resolution analysis of intrinsically disordered proteins using NMR spectroscopy. Methods 138-139:39-46
Pui, Ching-Hon; Liu, Yiwei; Relling, Mary V (2018) How to solve the problem of hypersensitivity to asparaginase? Pediatr Blood Cancer 65:
Mukkada, Sheena; Smith, Cristel Kate; Aguilar, Delta et al. (2018) Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting. Pediatr Blood Cancer 65:
Zhong, Bo; Maharaj, Anil; Davis, Abigail et al. (2018) Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis study. J Pharm Biomed Anal 156:97-103
van Oosterwijk, Jolieke G; Buelow, Daelynn R; Drenberg, Christina D et al. (2018) Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia. J Clin Invest 128:369-380

Showing the most recent 10 out of 6764 publications